Comparative Evaluation of Ayurvedic Medicines (Navkarshika Kashaya Ghan Vati and Amrita Guggulu) with Shatahwadi Taila in Patients with Gout (Vatarakta)

A CLINICO COMPARATIVE TRIAL TO EVALUATE THE EFFICACY OF NAVKARSHIKA KASHAYA GHAN VATI AND AMRITA GUGGULU ALONG WITH SHATAHWADI TAILA IN THE MANAGEMENT OF VATARAKTA (GOUT) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112502

Enrollment

Registered

2026-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participant of either gender. 2.Participant with age 20 to 60 years. 3.Serum Uric acid level more than 7mg/dl for male and 6mg/dl for female.6 4.Participant with classical sign and symptoms of Vatarakta.

Exclusion criteria

Exclusion criteria: 1.Pregnancy and lactating mother. 2. Participant without written consent form. 3. Female Participant with PCOD and heavy Bleeding in Menses. 4.Participant presenting with tophi, cellulitis,uncontrolled diabetes and hypertension, renal,severe cardiac disease , liver disorder, bone deformities, rheumatoid arthritis and Osteoarthritis.

Design outcomes

Primary

Measure	Time frame
It is expected that at the end of study we would be demonstrate that Navakarshikadi Kashaya Ghan Vati and Amrita guggulu Along with Shatahwadi Taila will be efficient in the management of Vatarakta or not.Timepoint: 18 months	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Surbhi Parihar

Pt khushilal sharma govt (Auto) ayurveda college and institute bhopal

dr.rajeshmeshram@gmail.com9425024816

Outcome results